Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia

Abstract Case Approximately 3%‐25% of cases of endometrial carcinoma (EC) or atypical endometrial hyperplasia (AH) occur in women aged <40 years and conservative treatment with high‐dose medroxyprogesterone acetate (MPA) is administered to women who wish to preserve their fertility. Here is repor...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Toshiya Matsuzaki, Takeshi Iwasa, Takako Kawakita, Yuri Yamamoto, Akiko Abe, Aki Hayashi, Kiyohito Yano, Masato Nishimura, Akira Kuwahara, Minoru Irahara
Format: Artigo
Langue:Inglês
Publié: Wiley 2018-07-01
Collection:Reproductive Medicine and Biology
Sujets:
assisted reproductive technology
atypical endometrial hyperplasia
conservative treatment
endometrial carcinoma
medroxyprogesterone acetate
Accès en ligne:https://doi.org/10.1002/rmb2.12209
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires